Advicenne
Manufacturing · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
262 Rue Du Faubourg Saint Honore, Paris,...Phone Number
+33185733620Website
www.advicenne.comRevenue
$6.9 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Advicenne
Advicenne is a specialty pharmaceutical company focused on developing innovative therapies for patients affected by rare renal diseases with limited treatment options. The company leverages expertise in drug reformulation and delivery technologies to create safe and effective treatments designed for both children and adults. Through its focus on addressing unmet medical needs in nephrology, Advicenne aims to improve patient outcomes and enhance quality of life by advancing targeted therapies for rare kidney disorders.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Advicenne your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Advicenne
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Advicenne recently announced quarterly report
Check if Advicenne has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Advicenne has new funding data
Check out if Advicenne is spiking on competitors!
Advicenne, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Advicenne had a recent Job posting/layoffs
Product Launch: Get notified when Advicenne launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Advicenne
Find more new buyers
Company Profile Activity
Activity Insights
Advicenne is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Advicenne is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Advicenne.
Advicenne financials insights
Gather financial insights about Advicenne, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Unspecified
$17.2M
Stock Offering
$36.4M
2026
Debt
$4.3M
Advicenne Tech Stack
A closer look at the technologies used by Advicenne
See more technologies
Most Recent Scoops
Person-Based
Pharmaceuticals
Person-Based
Pharmaceuticals
Person-Based
Earnings, Finance
Person-Based
Pharmaceuticals
Funding
Funding
Advicenne News & Media
Advicenne Secures Its Cash Runway to Q2 2027 through a Bond Financing of a Nominal ...
PARIS, June 22, 2026--Regulatory News: Advicenne S.A. ("Advicenne" or the "Company") (Euronext Growth Paris - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases, announced today that it has secured a two-tranche financing of a nominal amount of up to €3.8 million, through the issuance of bonds subscribed by Cemag Invest and Didier Laurens, Chairman of the Board and CEO of Advicenne,Advicenne 2024 Universal Registration Document Made Available
PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris ALDVI - FR0013296746), a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those suffering from rare renal diseases, announces today that its 2024 Universal Registration Document has been filed with the French Autorité des Marchés Financiers (AMF). The Universal Registration Document includes the annual report, the management report, the Board of Directors' reAdvicenne Announces the Approval of All Resolutions Supported by the Board of Directors ...
Regulatory News: The Combined General Meeting of shareholders of Advicenne (Euronext Growth Paris ALDVI - FR0013296746) (Paris:ALDVI), a specialty phaAvanzanite Bioscience Expands Partnership With Advicenne in Additional European Countries
AMSTERDAM--(BUSINESS WIRE)-- #dRTA--Avanzanite's expanded collaboration with Advicenne now includes Ireland, Cyprus and Malta in addition to existing markets (DE, AT, CH, GR, LI).
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Advicenne
Sign Up For FreeTo access detailed company insights
Advicenne is a specialty pharmaceutical company focused on developing innovative therapies for patients affected by rare renal diseases with limited treatment options. The company leverages expertise in drug reformulation and delivery technologies to create safe and effective treatments designed for both children and adults. Through its focus on ad... Read More
